Perbedaan Estee Gold Feet Tbk. dan Organon Pharma Indonesia Tbk.: Estee Gold Feet Tbk. diperdagangkan di Rp1.400 (kapitalisasi pasar 3,68 T, volume 24 jam 168,3 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Estee Gold Feet Tbk. jauh lebih besar — sekitar 35,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| EURO | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 3,68 T | 104,4 M |
Volume | 168,3 rb | — |
Lot | 1,68 rb | — |
Perputaran | 233,12 jt | — |
Harga Rata-rata | 1.385,12 | — |
Nilai Transaksi | 233,12 jt | — |
Harga Ekuilibrium Indikatif | 1.400 | — |
Volume Ekuilibrium Indikatif | 71 | — |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Estee Gold Feet Tbk (Company) was established by Notarial Deed No. 32 dated January 21, 1980 from Abdoel Sjoekoer, S.H., Notary in Jakarta. The Company started its commercial operations in 1986. The Company is controlled by its immediate parent company, PT Timmsvale, a company domiciled in Indonesia. The ultimate beneficial owners of the Company are Johansen Ngian.
Selengkapnya di halaman EURO →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →